Effect of influenza a infection on umbilical cord blood natural killer function regulation with interleukin-15

Journal of Infectious Diseases

Volumn 205, Issue 5, 2012, Pages 745-756

  Lin, Syh Jae ^a   Cheng, Po Jen ^c   Lin, Tzou Yien ^b   Lee, Pei Tzu ^c   Hsiao, Hsiu Shan ^c   Kuo, Ming Ling ^d  

^a Department of Pediatrics   (Taiwan)

^b Division of Pediatric Infectious Diseases   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 15; LYSOSOME ASSOCIATED MEMBRANE PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PERFORIN; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL STRAIN K 562; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOREGULATION; INFLUENZA A; INTERFERON PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE FUNCTION; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PURIFICATION; UMBILICAL CORD BLOOD; UPREGULATION;

ADULT; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; APOPTOSIS; CYTOTOXICITY, IMMUNOLOGIC; DOWN-REGULATION; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INFLUENZA A VIRUS; INFLUENZA, HUMAN; INTERFERON-GAMMA; INTERLEUKIN-15; K562 CELLS; KILLER CELLS, NATURAL; LECTINS, C-TYPE; LEUKOCYTES, MONONUCLEAR; LYSOSOMAL-ASSOCIATED MEMBRANE PROTEIN 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; PERFORIN; STATISTICS, NONPARAMETRIC; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84863116715     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir843     Document Type: Article

References (44)

1. Lamb RA, Krug RM. Orthomyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM, eds. Fields virology. Philadelphia, PA: Lippincott Williams & Wilkins, 2001:1533-79.
2. Doherty PC, Topham DJ, Tripp RA, Cardin RD, Brooks JW, Stevenson PG. Effector CD41 and CD81 T-cell mechanisms in the control of respiratory virus infections. Immunol Rev 1997; 159:105-17. (Pubitemid 27499863)
3. Graham MB, Braciale TJ. Resistance to and recovery from lethal influenza virus infection in B lymphocyte-deficient mice. J Exp Med 1997; 186:2063-8. (Pubitemid 28013692)
4. Benton KA, Misplon JA, Lo CY, Brutkiewicz RR, Prasad SA, Epstein SL. Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells. J Immunol 2001; 166:7437-45. (Pubitemid 32525621)
5. Liu B,Mori I,HossainMJ, Dong L, Takeda K, Kimura Y. Interleukin-18 improves the early defense system against influenza virus infection by augmenting natural killer cell-mediated cytotoxicity. J Gen Virol 2004; 85:423-8. (Pubitemid 38262577)
6. Robertson MJ, Ritz J. Biology and clinical relevance of human natural killer cells. Blood 1990; 76:2421-38.
7. Tay CH, Szomolanyi-Tsuda E, Welsh RM. Control of infections by NK cells. Curr Top Microbiol Immunol 1998; 230:193-220. (Pubitemid 28183724)
8. Biron CA, Nguyen KB, Pien GC, Cousens LP, Salazar-Mather TP. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999; 17:189-220. (Pubitemid 29241123)
9. Ferlazzo G, Tsang M-L, Moretta L, Melioli G, Steinman RM, Münz C. Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 2002; 195:343-51. (Pubitemid 34461492)
10. Jinushi M, Takehara T, Tatsumi T, et al. Negative regulation of NK cell activities by inhibitory receptor CD94/NKG2A leads to altered NK cellinduced modulation of dendritic cell functions in chronic hepatitis C virus infection. J Immunol 2004; 173:6072-81. (Pubitemid 39487763)
11. Guo H, Kumar P, Malarkannan S. Evasion of natural killer cells by influenza virus. J Leukoc Biol 2011; 89:189-94.
12. Mao H, Tu W, Liu Y, et al. Inhibition of human natural killer cell activity by influenza virions and hemagglutinin. J Virol 2010; 84:4148-57.
13. Mao H, Tu W, Qin G, et al. Influenza virus directly infects human natural killer cells and induces cell apoptosis. J Virol 2009; 83:9215-22.
14. Izurieta H, Thompson W, Kramarz P, et al. Influenza and the rates of hospitalization for respiratory diseases among infants and young children. N Engl J Med 2000; 342:232-9. (Pubitemid 30058954)
15. Coffin S, Zaoutis T, Rosenquist A, et al. Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics 2007; 119:740-8. (Pubitemid 46556673)
16. Bhat N, Wright JG, Broder KR, et al. Influenza-associated deaths among children in the United States, 2003-2004. N Engl J Med 2005; 353:2559-67. (Pubitemid 41785893)
17. Jenkins M, Mills J, Kohl S. Natural killer cytotoxicity and antibodydependant cellular cytotoxicity of HIV-infected cells by leukocytes from human neonates and adults. Pediatr Res 1993; 33:469-74. (Pubitemid 23127799)
18. Merrill JD, Sigaroundinia M, Kohl S. Characterization of natural killer and antibody-dependent cellular cytotoxicity of preterm infants against human immunodeficiency virus-infected cells. Pediatr Res 1996; 40: 498-503. (Pubitemid 26282587)
19. Lin SJ, Yan DC. ICAM-1 (CD54) expression on T-lymphocytes and natural killer cells from umbilical cord blood-regulation with interleukin (IL)-12 and IL-15. Cytokines Cell Mol Ther 2000; 6: 161-4.
20. Verneris MR, Miller JS. The phenotypic and functional characteristics of umbilical cord blood and peripheral blood natural killer cells. Br J Haematol 2009; 147:185-91.
21. Guidotti LG, Chisari FV. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001; 19:65-91. (Pubitemid 32368030)
22. Robertson MJ. Role of chemokines in the biology of natural killer cells. J Leuko Biol 2002; 71:173-83.
23. Fawaz LM, Sharif-skari E, Menezez J. Up-regulation of NK cytotoxic activity via IL-15 production by different viruses: a comparative study. J Immunol 1999; 163:4473-80. (Pubitemid 29474516)
24. Fehniger TA, Caligiuri MA. Interleukin15: biology and relevance to human disease. Blood 2001; 97:14-32. (Pubitemid 32061238)
25. Mueller YM, Bojczuk PM, Halstead ES, et al. IL-15 enhances survival and function of HIV-specific CD81 T cells. Blood 2003; 101:1024-9. (Pubitemid 36139375)
26. Mararks-Konczalik J, Dubois S, Losi JM, et al. IL-2-induced activationinduced cell death is inhibited in IL-15 transgenic mice. Proc Natl Acad Sci USA 2000; 97:11445-50.
27. Vujanovic L, Szymkowski DE, Alber S, Watkins SC, Vujanovic NL, Butterfield LH. Virally infected and matured human dendritic cells activate natural killer cells via cooperative activity of plasma membrane-bound TNF and IL-15. Blood 2010; 116:575-83.
28. Castillo EF, Stonier SW, Frasca L, Schluns KS. Dendritic cells support the in vivo development and maintenance of NK cells via IL-15 transpresentation. J Immunol 2009; 183:4948-56.
29. Lennette DA. General principles for laboratory diagnosis of viral, rickettsial, and chlamydial infections. In: Lennette EH, Lennette DA, Lennette ET, eds. Diagnostic procedures for viral, rickettsial, and chlamydial infections. Washington, DC: American Public Health Association, 1995:3-25.
30. Vermes I, Haanen C, Steffens-Nakken H, Reutelingsperger C. A novel assay for apoptosis: flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin-V. J Immunol Methods 1995; 184:39-51.
31. Alter G, Malenfant JM, Altfeld M. CD107a as a functional marker for the identification of natural killer cell activity. J Immunol Methods 2004; 294:15-22. (Pubitemid 39626587)
32. Lin SJ, Cheng PJ, Huang YJ, KuoML. Evaluation of interleukin (IL)-12/IL-15 activated umbilical cord blood natural killer cell cytotoxic function by a propidium-iodide based flow cytometry. Pediatr Allergy Immunol 2004; 15:79-85.
33. Du N, Zhou J, Lin X, et al. Differential activation of NK cells by influenza A pseudotype H5N1 and 1918 and 2009 pandemic H1N1 viruses. J Virol 2010; 84:7822-31.
34. Guo H, Kumar P, Moran TM, Garcia-Sastre A, Zhou Y,Malarkannan S. The functional impairment of natural killer cells during influenza virus infection. Immunol Cell Biol 2009; 87:579-89.
35. Small CL, Shaler CR, McCormick S, et al. Influenza infection leads to increased susceptibility to subsequent bacterial superinfection by impairing NK cell responses in the lung. J Immunol 2010; 184:2048-56.
36. Mandelboim O, Lieberman N, Lev M, et al. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 2001; 409:1055-60. (Pubitemid 32204059)
37. Jost S, Reardon J, Peterson E, Poole D, Bosch R, Alter G, Altfeld M. Expansion of 2B41 natural killer (NK) cells and decrease in NKp461 NK cells in response to influenza. Immunol 2011; 132:516-26.
38. Denney L, Aitken C, Li CK, et al. Reduction of natural killer but not effector CD8 T lymphocytes in three consecutive cases of severe/lethal H1N1/09 influenza A virus infection. PLoS One 2010; 5:e10675.
39. Tomescu C, Chehimi J, Maino VC, Montaner LJ. Retention of viability, cytotoxicity, and response to IL-2, IL-15, or IFN-alpha by human NK cells after CD107a degranulation. J Leukoc Biol 2009; 85:871-6.
40. Dalle JH, Menezes J, Wagner E, et al. Characterization of cord blood natural killer cells: implications for transplantation and neonatal infections. Pediatr Res 2005; 57:649-55. (Pubitemid 40578033)
41. Weiss ID, Wald O, Wald H, et al. IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner. J Interferon Cytokine Res 2010; 30:439-49.
42. He XS, Draghi M, Mahmood K, et al. T cell-dependent production of IFN-c by NK cells in response to influenza A virus. J Clin Invest 2004; 114:1812-9. (Pubitemid 40385537)
43. He XS, Holmes TH, Zhang C, et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 2006; 80:11756-66. (Pubitemid 44788888)
44. Ahlenstiel G, Martin MP, Gao X, Carrington M, Rehermann B. Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses. J Clin Invest 2008; 118:1017-26. (Pubitemid 351364609)